Bortezomib‐Encapsulated Dual Responsive Copolymeric Nanoparticles for Gallbladder Cancer Targeted Therapy

Abstract Gallbladder cancer (GBC) is a rare but the most malignant type of biliary tract tumor. It is usually diagnosed at an advanced stage and conventional treatments are unsatisfactory. As a proteasome inhibitor, bortezomib (BTZ) exhibits excellent antitumor ability in GBC. However, the long‐term...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mingyu Chen, Sarun Juengpanich, Shijie Li, Win Topatana, Ziyi Lu, Qiang Zheng, Jiasheng Cao, Jiahao Hu, Esther Chan, Lidan Hou, Jiang Chen, Fang Chen, Yu Liu, Sukanda Jiansirisomboon, Zhen Gu, Suparat Tongpeng, Xiujun Cai
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2022-03-01
coleção:	Advanced Science
Assuntos:	drug delivery gallbladder cancer nanomedicine proteasome inhibitor targeted therapy
Acesso em linha:	https://doi.org/10.1002/advs.202103895
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!